ArticleTumour virus research2026
HPV8-E6 drives coordinated transcriptional and epigenetic reprogramming of keratinocytes.
Article in Tumour virus research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Beta human papillomaviruses (betaHPVs) act as cofactors in keratinocyte carcinogenesis, but how they reprogram host gene regulation remains unclear. Here, we combined transcriptomic, small RNA and epigenomic profiling to dissect the impact of betaHPV8 oncogene expression on keratinocytes. The viral E6 protein emerged as the major driver of host gene regulatory reprogramming, repressing epidermal differentiation programs, whereas E7 induced fewer, complementary changes. Small RNA sequencing revealed E6-dependent remodeling of the microRNA (miRNA) landscape, and integrative analyses linked miRNA regulation to reciprocal changes in target gene expression, indicating a role for epigenetic post-transcriptional regulation in the E6-driven phenotype. Whole-genome bisulfite sequencing showed widespread E6-dependent DNA methylation changes at promoters, enhancers, and gene bodies. Motif enrichment analysis showed that hypermethylation silenced nuclear receptor and developmental regulators, while hypomethylation was associated with enrichment of AP1 and STAT3 binding motifs. Analysis of clinical specimens further revealed that betaHPV DNA was enriched in actinic keratoses and cutaneous squamous cell carcinomas displaying stem cell-like methylation profiles, linking viral activity to progenitor-associated tumorigenesis. Together, our data define a multilayered mechanism by which HPV8 destabilizes keratinocyte lineage identity which may create a cellular state permissive for malignant progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.